AdvisorShares Investments LLC cut its stake in shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD – Free Report) by 33.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 74,666 shares of the company’s stock after selling 38,242 shares during the period. AdvisorShares Investments LLC owned 0.25% of […]
Q2 2024 Earnings Estimate for Relmada Therapeutics, Inc (NASDAQ:RLMD) Issued By Leerink Partnrs themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
RLMD Stock Earnings: Relmada Therapeutics Beats EPS for Q1 2024 biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
Relmada Therapeutics (RLMD) Set to Announce Earnings on Wednesday theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
CORAL GABLES, Fla., May 6, 2024 /PRNewswire/ Relmada Therapeutics, Inc. , a late-stage biotechnology company addressing diseases of the central nervous system , today announced that it will.